SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-364331
Filing Date
2017-12-08
Accepted
2017-12-08 06:14:13
Documents
3
Effectiveness Date
2017-12-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d268150ds8.htm S-8 71398
2 EX-5.1 d268150dex51.htm EX-5.1 4414
3 EX-23.1 d268150dex231.htm EX-23.1 1661
  Complete submission text file 0001193125-17-364331.txt   78534
Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-221946 | Film No.: 171246036
SIC: 2836 Biological Products, (No Diagnostic Substances)